Home › Trial NCT00072345
Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
- Trial IDNCT00072345
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorMemorial Sloan Kettering Cancer Center
- Enrollment—
- Start date2003-07
- ConditionsIntraocular Melanoma · Melanoma (Skin)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.